Innate Pharma Stock Quote IPH - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.92

Bid

1.918

Ask

1.96

Volume

36,430

1.914 Day's Range 1.95

1.332 52 Week Range 2.80

Market Cap

610.887M

Previous Close

1.934

Open

1.95

Last Trade

148

1.92

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

143,539

Shares Outstanding

318,170,508

Dividend Yield

PE Ratio

-80.67

Earnings Per Share (EPS)

-0.02

Revenue

61.64M

Net Profit

-7.57M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.innate-pharma.com

Headquarters

Marseille, Bouches-du-rhone, Fra

Founded

Innate Pharma is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker IPH. The last closing price for Innate Pharma was 1.93 €. Over the last year, Innate Pharma shares have traded in a share price range of 1.332 € to 2.80 €.

Innate Pharma currently has 318,170,508 shares outstanding. The market capitalization of Innate Pharma is 615.34 € million. Innate Pharma has a price to earnings ratio (PE ratio) of -80.67.

Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its management will present and host 1x1 meetings at the 43rd Annual J.P...

Innate Pharma Presents Lacutamab Improved Health-related Quality of Life Data at ASH 2024 From TELLOMAK Phase 2 Study in Patients With Cutaneous T Cell Lymphoma

Findings reveal promising early signs that lacutamab may help alleviate some of the most distressing symptoms of cutaneous T cell lymphomas Regulatory News: Innate Pharma SA (Euronext Paris:...

Innate Pharma et l’Institut d’Innovation pour le Lymphome Folliculaire (IFLI) annoncent un investissement jusqu’à 7,9 millions de dollars de l’IFLI pour soutenir le développement d’IPH6501 dans le lymphome folliculaire

Innate recevra 3 millions de dollars en paiement initial et jusqu’à 4,9 millions de dollars en tranches d’investissements conditionnelles de l’Institut d’Innovation pour le Lymphome Folliculaire...

Innate Pharma partage les présentations sélectionnées pour le congrès annuel de l’ASH 2024

Regulatory News: Innate Pharma SA (Euronext Paris : IPH ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des abstracts concernant les données portant sur la qualité de vie...

Innate Pharma Releases Its 2025 Financial Calendar

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2025 financial calendar: March 27, 2025: Publication of 2024 financial...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.19	-9.00473933649	2.11	2.11	1.9	181850	1.99875941	DE
4	0.47	32.4137931034	1.45	2.49	1.332	268270	1.82387883	DE
12	-0.1	-4.9504950495	2.02	2.49	1.332	143539	1.76226101	DE
26	-0.13	-6.34146341463	2.05	2.49	1.332	88336	1.83517431	DE
52	-0.6	-23.8095238095	2.52	2.8	1.332	85130	2.10445407	DE
156	-2.47	-56.2642369021	4.39	4.73	1.332	136837	2.72135541	DE
260	-3.84	-66.6666666667	5.76	8.3	1.332	275032	4.08821345	DE

IPH - Frequently Asked Questions (FAQ)

What is the current Innate Pharma share price?

The current share price of Innate Pharma is 1.92 €

How many Innate Pharma shares are in issue?

Innate Pharma has 318,170,508 shares in issue

What is the market cap of Innate Pharma?

The market capitalisation of Innate Pharma is EUR 615.34M

What is the 1 year trading range for Innate Pharma share price?

Innate Pharma has traded in the range of 1.332 € to 2.80 € during the past year

What is the PE ratio of Innate Pharma?

The price to earnings ratio of Innate Pharma is -80.67

What is the cash to sales ratio of Innate Pharma?

The cash to sales ratio of Innate Pharma is 9.91

What is the reporting currency for Innate Pharma?

Innate Pharma reports financial results in EUR

What is the latest annual turnover for Innate Pharma?

The latest annual turnover of Innate Pharma is EUR 61.64M

What is the latest annual profit for Innate Pharma?

The latest annual profit of Innate Pharma is EUR -7.57M

What is the registered address of Innate Pharma?

The registered address for Innate Pharma is 117 AVENUE DE LUMINY, BP 30191, MARSEILLE, BOUCHES-DU-RHONE, 13009

What is the Innate Pharma website address?

The website address for Innate Pharma is www.innate-pharma.com

Which industry sector does Innate Pharma operate in?

Innate Pharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EIFDSTour Eiffel DS	0.0432 € (800.00%)	89.74k
SEQUASequana medical NV	2.76 € (33.33%)	1.64M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M
ALPAUPaulic Meunerie SA	1.43 € (16.26%)	17.14k
GNROGeNeuro SA	0.081 € (15.38%)	330.33k
MLSMLSmalto	0.0125 € (-32.43%)	50
ALVIAVialife Sa	13.30 € (-27.72%)	7
MLMADMade	9.25 € (-15.91%)	255
ALALOAcheterLouerFR	0.23 € (-14.81%)	3.92k
ALLPLLepermislibre SA	0.397 € (-11.78%)	3.01k
ATOAtos SE	0.0023 € (-4.17%)	396.59M
BCPBanco Comercial Portugues SA	0.451 € (0.16%)	17.85M
LATLatecoere	0.0094 € (3.30%)	9.13M
ALVERVergnet	0.0021 € (-4.55%)	8.37M
ALEUPEuroplasma	0.0484 € (28.38%)	6.54M